Table of Contents

2019-2024 Global CAR T-Cell Therapy Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global CAR T-Cell Therapy Market Size 2014-2024
2.1.2 CAR T-Cell Therapy Market Size CAGR by Region
2.2 CAR T-Cell Therapy Segment by Type
2.2.1 Allogeneic
2.2.2 Autologous
2.3 CAR T-Cell Therapy Market Size by Type
2.3.1 Global CAR T-Cell Therapy Market Size Market Share by Type (2014-2019)
2.3.2 Global CAR T-Cell Therapy Market Size Growth Rate by Type (2014-2019)
2.4 CAR T-Cell Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Cancer Research Centers
2.4.3 Others
2.5 CAR T-Cell Therapy Market Size by Application
2.5.1 Global CAR T-Cell Therapy Market Size Market Share by Application (2014-2019)
2.5.2 Global CAR T-Cell Therapy Market Size Growth Rate by Application (2014-2019)

3 Global CAR T-Cell Therapy by Players
3.1 Global CAR T-Cell Therapy Market Size Market Share by Players
3.1.1 Global CAR T-Cell Therapy Market Size by Players (2017-2019)
3.1.2 Global CAR T-Cell Therapy Market Size Market Share by Players (2017-2019)
3.2 Global CAR T-Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CAR T-Cell Therapy by Regions
4.1 CAR T-Cell Therapy Market Size by Regions
4.2 Americas CAR T-Cell Therapy Market Size Growth
4.3 APAC CAR T-Cell Therapy Market Size Growth
4.4 Europe CAR T-Cell Therapy Market Size Growth
4.5 Middle East & Africa CAR T-Cell Therapy Market Size Growth

5 Americas
5.1 Americas CAR T-Cell Therapy Market Size by Countries
5.2 Americas CAR T-Cell Therapy Market Size by Type
5.3 Americas CAR T-Cell Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC CAR T-Cell Therapy Market Size by Countries
6.2 APAC CAR T-Cell Therapy Market Size by Type
6.3 APAC CAR T-Cell Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe CAR T-Cell Therapy by Countries
7.2 Europe CAR T-Cell Therapy Market Size by Type
7.3 Europe CAR T-Cell Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa CAR T-Cell Therapy by Countries
8.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type
8.3 Middle East & Africa CAR T-Cell Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global CAR T-Cell Therapy Market Forecast
10.1 Global CAR T-Cell Therapy Market Size Forecast (2019-2024)
10.2 Global CAR T-Cell Therapy Forecast by Regions
10.2.1 Global CAR T-Cell Therapy Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global CAR T-Cell Therapy Forecast by Type
10.8 Global CAR T-Cell Therapy Forecast by Application

11 Key Players Analysis
11.1 Celgene (Juno Therapeutics)
11.1.1 Company Details
11.1.2 CAR T-Cell Therapy Product Offered
11.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Celgene (Juno Therapeutics) News
11.2 Novartis
11.2.1 Company Details
11.2.2 CAR T-Cell Therapy Product Offered
11.2.3 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Novartis News
11.3 Gilead (Kite Pharma)
11.3.1 Company Details
11.3.2 CAR T-Cell Therapy Product Offered
11.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Gilead (Kite Pharma) News
11.4 Pfizer
11.4.1 Company Details
11.4.2 CAR T-Cell Therapy Product Offered
11.4.3 Pfizer CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Pfizer News
11.5 CARsgen Therapeutics
11.5.1 Company Details
11.5.2 CAR T-Cell Therapy Product Offered
11.5.3 CARsgen Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 CARsgen Therapeutics News
11.6 Autolus Therapeutics
11.6.1 Company Details
11.6.2 CAR T-Cell Therapy Product Offered
11.6.3 Autolus Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Autolus Therapeutics News
11.7 Aurora BioPharma
11.7.1 Company Details
11.7.2 CAR T-Cell Therapy Product Offered
11.7.3 Aurora BioPharma CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Aurora BioPharma News
11.8 Sorrento Therapeutics
11.8.1 Company Details
11.8.2 CAR T-Cell Therapy Product Offered
11.8.3 Sorrento Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Sorrento Therapeutics News
11.9 Mustang Bio
11.9.1 Company Details
11.9.2 CAR T-Cell Therapy Product Offered
11.9.3 Mustang Bio CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Mustang Bio News
11.10 Bluebird Bio
11.10.1 Company Details
11.10.2 CAR T-Cell Therapy Product Offered
11.10.3 Bluebird Bio CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Bluebird Bio News
11.11 Collectis
11.12 Allogene Therapeutics
11.13 Celyad

12 Research Findings and Conclusion